Pfizer
Indra Mani Sharma is a Senior Scientist at Pfizer since March 2023, specializing in mRNA Vaccine Bioprocess Research and Development. Prior to this role, Indra served as a Research Fellow at the National Cancer Institute from November 2020 to March 2023, where strategies were devised to investigate non-functional RNA decay in human cells and the role of pseudouridylation in RNA stability was uncovered. Indra held the position of Postdoctoral Scientist at The Johns Hopkins University from December 2014 to November 2020, contributing to discoveries regarding initiation factor 3 in ribosome biogenesis and translation initiation, as well as critical folding steps in bacterial ribosomal RNA. Indra obtained a PhD in Biochemistry from the Indian Institute of Science in September 2014, following a Master's degree in Biotechnology from Banaras Hindu University and a Bachelor's degree in Chemistry, Botany, and Zoology from Veer Bahadur Singh Purvanchal University.
This person is not in any teams
Pfizer
605 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.